Bovie Medical Corporation to Participate in Biotech Showcase 2017
January 03 2017 - 8:00AM
Business Wire
Bovie Medical Corporation (NYSEMKT:BVX) (the “Company”), a maker
of medical devices and supplies and the developer of J-Plasma®, a
patented new surgical product, announced today that Robert L.
Gershon, Chief Executive Officer of the Company, and Jack McCarthy,
Chief Commercialization Officer, will participate in the 9th
Annual Biotech Showcase Conference in San Francisco.
The conference will be held at the Hilton San Francisco Union
Square in San Francisco, where Mr. Gershon will present to
investors on Tuesday, January 10 at 11.00am PST, 2017. Mr.
Gershon will discuss the Company and J-Plasma®, its
transformational surgical product.
Mr. Gershon will also present at Medtech Showcase, which is part
of the Biotech Showcase conference, on Wednesday, January 11 at
10.30am PST, at the Parc 55 San Francisco Hotel in Union
Square.
Biotech Showcase is an investor and networking conference
devoted to providing private and public biotechnology and life
sciences companies with an opportunity to present to and meet with
investors and industry executives.
If you would like to schedule a one-on-one meeting with Bovie
Medical management at the event, please register and proceed
through the event's partnering system or contact MBS Value
Partners.
About Bovie Medical Corporation
Bovie Medical Corporation is a leading maker of medical devices
and supplies as well as the developer of J-Plasma®, a patented new
plasma-based surgical product for cutting and coagulation.
J-Plasma® utilizes a helium ionization process to produce a stable,
focused beam of ionized gas that provides surgeons with greater
precision, minimal invasiveness and an absence of conductive
currents through the patient during surgery. Bovie Medical
Corporation is also a leader in the manufacture of a range of
electrosurgical products and technologies, marketed through both
private labels and the Company’s own well-respected brands (Bovie®,
Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also
leverages its expertise through original equipment manufacturing
(OEM) agreements with other medical device manufacturers. For
further information about the Company’s current and new products,
please refer to the Investor Relations section of Bovie Medical
Corporation’s website www.boviemed.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170103005358/en/
Investor Relations:MBS Value PartnersLynn Morgen / Jane
Searle212-750-5800investor.relations@boviemed.com
Bovie (AMEX:BVX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bovie (AMEX:BVX)
Historical Stock Chart
From Sep 2023 to Sep 2024